Medpace Holdings, Inc. (MEDP)

NasdaqGS Currently up 11.87 (+1.94%) in today's trading session

6 members of Congress have disclosed 17 trades in Medpace Holdings, Inc. (MEDP) via STOCK Act filings. The most recent disclosure was a purchase by David J. Taylor on 15 May 2026. The most active traders have been David J. Taylor (6), Gilbert Cisneros (5), and Lisa McClain (2). Aggregate disclosed activity totals roughly $72K in purchases and $88.5K in sales (midpoint estimates from bracketed disclosure amounts).

Medpace Holdings, Inc. is currently trading at $630.19, positioned at 84% of its 52-week range ($373.00 – $677.90).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$630.19
24h Change
+11.87 (+1.94%)
52 Week Range
$373.00$677.90
View on NASDAQ

Medpace Holdings, Inc. Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for MEDP

Select to highlight on chart
5 transactions
Compliance: 100%
David J. Taylor15 May 202628 May 2026PurchaseStock$1,001 - $15,000+50.34%
David J. Taylor15 May 202628 May 2026PurchaseStock$1,001 - $15,000+50.34%
David J. Taylor26 Feb 20266 Mar 2026PurchaseStock$1,001 - $15,000+43.85%
David J. Taylor29 Jan 20262 Feb 2026PurchaseStock$1,001 - $15,000+5.40%
David J. Taylor16 Jan 20262 Feb 2026SaleStock$1,001 - $15,000N/A

See every trade

Sign in free to see the full trade history for this stock.

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$17.39B

Volume

302.65K

Beta

1.15

P/E Ratio

36.94

Fundamentals

EPS

$17.06

Div. Yield

-

Open

$624.02

Day Range

$619.62 – $632.60

Company Information

Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NASDAQ · USD
Country
US
CEO
August James Troendle
IPO Date
2016-08-11

Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services. The company assists pharmaceutical, biotechnology, and medical device clients thr...

Earnings

Next Report

Q3 2026

28 Oct

EPS Est.

$4.45

Rev. Est.

$714.3M

Days Until

35

Recent Quarters

Q2 202622 Jul
EPS$4.25
Beat 6.8%
Q1 202622 Apr
EPS$4.28
Beat 9.2%
Q4 20259 Feb
EPS$4.67
Beat 11.5%
Q3 202522 Oct
EPS$3.86
Beat 9.3%
Q2 202521 Jul
EPS$3.10
Beat 4.0%
Q1 202521 Apr
EPS$3.67
Beat 19.9%
Q4 202410 Feb
EPS$3.67
Beat 24.0%
Q3 202421 Oct
EPS$3.01
Beat 8.3%
Q2 202422 Jul
EPS$2.75
Beat 8.3%
Q1 202422 Apr
EPS$3.20
Beat 29.6%
Q4 202312 Feb
EPS$2.46
Beat 10.8%
Q3 202323 Oct
EPS$2.22
Beat 8.3%
Q2 202324 Jul
EPS$1.93
Beat 1.1%
Q1 202324 Apr
EPS$2.27
Beat 26.1%
Q4 202213 Feb
EPS$2.12
Beat 18.4%
Q3 202224 Oct
EPS$2.05
Beat 39.5%
Q2 202225 Jul
EPS$1.46
Beat 11.4%
Q1 202225 Apr
EPS$1.69
Beat 34.1%
Q4 202114 Feb
EPS$1.32
Beat 5.6%
Q3 202125 Oct
EPS$1.29
Beat 20.6%
Q2 202126 Jul
EPS$1.06
Beat 7.1%
Q1 202126 Apr
EPS$1.14
Beat 14.0%
Q4 202015 Feb
EPS$1.35
Beat 8.9%
Q3 202026 Oct
EPS$1.09
Beat 1.9%
Q2 202027 Jul
EPS$0.68
Beat 65.8%
Q1 202028 Apr
EPS$0.80
Beat 6.7%
Q4 201924 Feb
EPS$0.85
Beat 13.3%
Q3 201928 Oct
EPS$0.71
Beat 0.0%
Q2 201929 Jul
EPS$0.81
Beat 26.6%
Q1 201929 Apr
EPS$0.64
Beat 6.7%
Q4 201825 Feb
EPS$0.76
Beat 13.4%
Q3 201829 Oct
EPS$0.67
Beat 8.1%
Q2 201830 Jul
EPS$0.61
Beat 45.2%
Q1 201830 Apr
EPS$0.60
Beat 39.5%
Q4 201726 Feb
EPS$0.39
Beat 2.6%
Q3 201730 Oct
EPS$0.40
Beat 11.1%
Q2 201731 Jul
EPS$0.38
Beat 26.7%
Q1 20171 May
EPS$0.34
Miss 8.1%
Q4 201627 Feb
EPS$0.35
Beat 2.9%
Q3 20163 Nov
EPS$0.40
Beat 14.3%
Q2 201616 Aug
EPS$0.09
Q1 201630 Jun
EPS$0.13
Q3 201531 Dec
EPS$-0.22
Q2 201530 Sept
EPS$-0.00
Q1 201530 Jun
EPS$0.00
Q4 201431 Mar
EPS$-0.00
Q4 201331 Mar
EPS$-0.03

4 politicians traded within 30 days

No dividend data available for this stock.

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations

MSFT

Microsoft Corporation

75
$498.00-3.61 (-0.72%)
Technology
5 politicians hold this stock
$34M in total holdings
5 politicians
View Stock

AMZN

Amazon.com, Inc.

53
$254.98-3.47 (-1.34%)
Consumer Cyclical
5 politicians hold this stock
Significant holdings value
5 politicians
View Stock

AAPL

Apple Inc.

48
$339.75+0.77 (+0.23%)
Technology
4 politicians hold this stock
Significant holdings value
4 politicians
View Stock

Frequently Asked Questions about MEDP

Which members of Congress have traded MEDP?
6 members of Congress have disclosed 17 trades in Medpace Holdings, Inc. (MEDP) under the STOCK Act. The most active traders are David J. Taylor, Gilbert Cisneros, and Lisa McClain.
When was MEDP most recently disclosed by Congress?
The most recent MEDP disclosure was a purchase by David J. Taylor on 15 May 2026.
What is the total disclosed congressional trading volume for MEDP?
Members of Congress have disclosed approximately $72K in MEDP purchases and $88.5K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
How can I track new congressional trades in MEDP?
This MEDP page updates as soon as new STOCK Act disclosures are filed for Medpace Holdings, Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.